Boothwyn Pharmacy LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Jun 9, 2025
  • Last warning letter 2026
Inspections 4 4 OAI
Recalls 4 0 Class I (0%)
Warning letters 3 Latest Jan 16, 2026
510(k) clearances 0 None on file

Boothwyn Pharmacy LLC has 4 FDA recalls, 4 inspections, 0 510(k) clearances and 3 compliance actions on record. FDA has issued 3 warning letters to Boothwyn Pharmacy LLC, the most recent on Jan 16, 2026. FDA has published 5 Form 483s for Boothwyn Pharmacy LLC.

What these totals cover: FDA records filed under the name "Boothwyn Pharmacy LLC" and its spelling variant "Boothwyn Pharmacy".

Latest recall
D-0606-2025 · Class II · Jul 9, 2025
Latest inspection
Jun 9, 2025 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls4Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections4Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions3Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Boothwyn Pharmacy LLC's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Boothwyn Pharmacy LLC: FDA inspections per year

2017: 1 inspection (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 1 warning letter, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 1 inspection (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (1 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 1 inspection (1 OAI), 1 warning letter, 4 recall records (0 Class I) 2026: 0 inspections (0 OAI), 1 warning letter, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600100
202511140
202411000
202311000
202200000
202100000
202000000
201900000
201800100
201711000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Boothwyn Pharmacy LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Boothwyn Pharmacy LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Boothwyn Pharmacy LLC FDA Warning Letters

3 warning letters from Jul 26, 2018 to Jan 16, 2026.

IssuedSubjectIssuing officeClose-out letter
Jan 16, 2026 · Letter on fda.gov Compounding Pharmacy/Adulterated Drug ProductsCenter for Drug Evaluation and Research (CDER)
Jun 9, 2025 · Letter on fda.gov Unapproved New Animal Drug/Adulterated/MisbrandedCenter for Veterinary Medicine
Jul 26, 2018 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Boothwyn Pharmacy LLC Form 483s

5 Form 483s published by FDA.

DateDocumentFEI
Jun 10, 2025 · Document on fda.gov 4831000076625
Oct 22, 2024 · Document on fda.gov 4831000076625
Aug 29, 2023 · Document on fda.gov Amended 4831000076625
Sep 8, 2021 · Document on fda.gov 4831000076625
Aug 11, 2017 · Document on fda.gov 4831000076625

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent recalls

4 recall records on Jul 9, 2025.

NumberClassProductDate
D-0606-2025Class IISemaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn PharmacyJul 9, 2025
D-0608-2025Class IISemaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn PharmacyJul 9, 2025
D-0609-2025Class IISemaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn PharmacyJul 9, 2025
D-0607-2025Class IIIFluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496Jul 9, 2025

Recent FDA inspections

4 inspections from Jun 16, 2017 to Jun 9, 2025.

DateSiteProductClassificationFEI
Jun 9, 2025Kennett Square, PADrugsOfficial Action Indicated (OAI)1000076625
Oct 22, 2024Kennett Square, PAVeterinaryOfficial Action Indicated (OAI)1000076625
Aug 29, 2023Kennett Square, PADrugsOfficial Action Indicated (OAI)1000076625
Jun 16, 2017Kennett Square, PADrugsOfficial Action Indicated (OAI)1000076625
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 3 compliance actions under Boothwyn Pharmacy LLC: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Jan 16, 2026.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 1000076625Kennett Square, PA4Jun 9, 2025

Boothwyn Pharmacy LLC and the FDA: common questions

Has Boothwyn Pharmacy LLC received an FDA warning letter?

Yes. FDA has issued 3 warning letters to Boothwyn Pharmacy LLC. The most recent is dated Jan 16, 2026, with the subject "Compounding Pharmacy/Adulterated Drug Products".

Has Boothwyn Pharmacy LLC received an FDA Form 483?

FDA has published 5 Form 483s for Boothwyn Pharmacy LLC in its reading room, the most recent dated Jun 10, 2025. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Boothwyn Pharmacy LLC?

The most recent FDA inspection on file ended Jun 9, 2025 at Kennett Square, PA and was classified OAI. FDA has 4 inspections of Boothwyn Pharmacy LLC on file, 4 of them classified OAI (official action indicated).

Has Boothwyn Pharmacy LLC had an FDA recall?

Yes. Boothwyn Pharmacy LLC has 4 FDA recalls on record. The most recent started Jul 9, 2025.

Need more than this page shows? Ask about Boothwyn Pharmacy LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.